Drug Trial Radar · NCT07502001
Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin
Last checked: Nov 19, 2026Latest source record: Mar 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
42
Planned (sponsor's estimate)
Start
Apr 8, 2026
Primary completion
Dec 1, 2026
Study completion Jun 2, 2027
Sponsor
- Lead sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 30, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to characterize the Influence of HDM1005 on gastric emptying and drug-drug interaction of HDM1005 and metformin, atorvastatin, warfarin, and digoxin in overweight/obese adult subjects.
Conditions
- Overweight
- Obesity
Interventions
AcetaminophenDrug
Single dose; Administered orally
MetforminDrug
Single dose; Administered orally
WarfarinDrug
Single dose; Administered orally
AtorvastatinDrug
Single dose; Administered orally
DigoxinDrug
Single dose; Administered orally
HDM1005 injectionDrug
Subcutaneous injection QW
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Concentration Time Curve From Time Zero to ∞ [ AUC(0- ∞)]Time frame: Up to Day 115
- Maximum observed concentration (Cmax)Time frame: Up to Day 115
- Area Under the Concentration Time Curve From Time Zero to t [ AUC(0- t)]Time frame: Up to Day 115
- Time of maximum observed concentration (Tmax)Time frame: Up to Day 115
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Second Affiliated Hospital of Anhui Medical University
Hefei, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.